Parnell Pharmaceuticals Holdings Total Liabilities 2014-2018 | PARNF
Parnell Pharmaceuticals Holdings total liabilities from 2014 to 2018. Total liabilities can be defined as the total value of all possible claims against the corporation.
Parnell Pharmaceuticals Holdings Annual Total Liabilities
(Millions of US $) |
| 2021 |
$56 |
| 2020 |
$50 |
| 2019 |
$45 |
| 2018 |
$39 |
| 2017 |
$32 |
| 2016 |
$29 |
| 2015 |
$20 |
| 2014 |
$12 |
| 2014 |
$0 |
| 2013 |
$26 |
| 2013 |
$0 |
| 2012 |
$0 |
Parnell Pharmaceuticals Holdings Quarterly Total Liabilities
(Millions of US $) |
| 2018-03-31 |
$33 |
| 2017-12-31 |
$32 |
| 2016-12-31 |
$29 |
| 2016-09-30 |
$20 |
| 2015-12-31 |
$20 |
| 2015-09-30 |
|
| 2015-06-30 |
$17 |
| 2015-03-31 |
|
| 2014-12-31 |
$12 |
| 2014-09-30 |
|
| 2014-06-30 |
$10 |
| 2014-03-31 |
$34 |
| 2013-06-30 |
$30 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and TERGIVE (R) are Parnell's premium osteoarthritis product suite. Parnell Pharmaceuticals Holdings Ltd. is headquartered in Alexandria, Australia.
|
